GNBT: Summary for Generex Biotechnology Corporati - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:19am EST - Canadian Markets open in 4 hours and 11 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Generex Biotechnology Corp. (GNBT)

On Feb 9: 0.588 USD 0.00 (0.00%)

MORE ON GNBT

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Generex Biotechnology Corporati (NCM:GNBT) Delayed quote data

Last Trade:	0.588 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	0.588
Open:	N/A
Bid:	0.575 x 400
Ask:	0.66 x 500
1y Target Est:	4.63

Day's Range:	N/A - N/A
52wk Range:	0.08 - 1.14
Volume:	0
Avg Vol (3m):	2,872,920
Market Cap:	146.13M
P/E (ttm):	N/A
EPS (ttm):	-0.248
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add GNBT to Portfolio

Download Data

HEADLINES

•	Large Pharma and Small Biotech Deals Expected to Increase in 2010
	at Seeking Alpha (Mon, Feb 8)

•	Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
	Indie Research (Thu, Feb 4)

•	Art Technology, Pacific Capital: Early Volume Plays
	at TheStreet.com (Mon, Feb 1)

•	Generex Announces Participation in 2010 Arab Health Congress
	GlobeNewswire (Mon, Jan 25)

•	Generex Biotechnology Highlights OTC Product Line at The Vitamin, Diet & Sports Nutrition Efficient Program Planning Session
	GlobeNewswire (Wed, Jan 20)

•	Generex Makes Podium Presentation of Vaccine Technology Platform With Cancer & Influenza Updates at PepTalk 2010
	GlobeNewswire (Tue, Jan 19)

•	[video] Progress on Diabetes, Cancer Treatments [138.0 min]
	at MarketWatch (Thu, Jan 14)

•	Generex Biotechnology Corporation: Introducing Revolutionary Cancer Immunotherapy While Redefining the Treatment for T1D, T2D
	Marketwire (Thu, Jan 14)

•	Generex Biotechnology Corporation to Present at the OneMedForum 2010 Conference
	GlobeNewswire (Wed, Jan 13)

•	Generex Receives Over $800,000 in Initial Purchase Orders for Crave-NX(TM) 7-Day Diet Aid Spray
	GlobeNewswire (Wed, Jan 13)

•	Major U.S. Pharmacy Chain to Market Generex's Crave-NX(TM) 7-Day Diet Aid Spray Throughout Its Nationwide Network of Over 7,000 Stores
	GlobeNewswire (Mon, Jan 11)

More Headlines for GNBT...

ANALYST

EPS Est (next year) (Jul-08) :	N/A
EPS Est (in 2 years) (Jul-09) :	N/A
Avg Rec (current)*:	1.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•